Journal article
TNFR2: The new Treg switch?
- Abstract:
- Three recent publications identified the TNF/TNR2 pathway as a new target to reduce graft-versus-host-disease through regulatory T cells activation or to potentially switch on a strong anti-leukemic effect through regulatory T cells blockade in allogeneic hematopoietic stem cell transplantation. This identified the TNF/TNR2 pathway as a swith and as a new target for immune checkpoint therapy to modulate the immune regulation in this clinical setting.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 505.7KB, Terms of use)
-
- Publisher copy:
- 10.1080/2162402X.2017.1373236
Authors
- Publisher:
- Taylor and Francis
- Journal:
- OncoImmunology More from this journal
- Volume:
- 7
- Issue:
- 1
- Article number:
- e1373236
- Publication date:
- 2017-09-21
- Acceptance date:
- 2017-08-25
- DOI:
- ISSN:
-
2162-402X
- Pmid:
-
29296530
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:731195
- UUID:
-
uuid:b57eac31-a8d1-4a9f-830e-41d42fe9ce57
- Local pid:
-
pubs:731195
- Source identifiers:
-
731195
- Deposit date:
-
2018-08-14
- ARK identifier:
Terms of use
- Copyright holder:
- Cohen and Wood
- Copyright date:
- 2017
- Notes:
-
Copyright © 2018 José L. Cohen and Kathryn J. Wood. Published with license by Taylor & Francis Group, LLC
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/),
which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way
If you are the owner of this record, you can report an update to it here: Report update to this record